Imagen de Portada

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda de Hoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	BJUI Compass
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
por: Sean Lim, et al.
Publicado: (2024)

Patients and generative AI: Who owns your diagnosis?
por: Asher Mandel, et al.
Publicado: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
por: Ryan Sutherland, et al.
Publicado: (2024)

Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
por: Kaushik P. Kolanukuduru, et al.
Publicado: (2024)

Effect of preoperative alpha‐blockers on ureteroscopy outcomes: A meta‐analysis of randomised trials
por: Naeem Bhojani, et al.
Publicado: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
por: Eric Margolis, et al.
Publicado: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025)

The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)

Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
por: Sophia M. Abusamra, et al.
Publicado: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
por: Ansh Bhatia, et al.
Publicado: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
por: Katherina Y. Chen, et al.
Publicado: (2026)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
por: Ailene E. Corona, et al.
Publicado: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
por: André B. Silva, et al.
Publicado: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
por: Nikhil Mayor, et al.
Publicado: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
por: Emilien Seizilles de Mazancourt, et al.
Publicado: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
por: Mohamad Baker Berjaoui, et al.
Publicado: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
por: Geneva Pantoja, et al.
Publicado: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
por: Lu Yu Kuo, et al.
Publicado: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
por: Pierre Allainguillaume, et al.
Publicado: (2026)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
por: Jeremy Cheng, et al.
Publicado: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
por: Jonathon Dawson, et al.
Publicado: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
por: Marcus Sondermann, et al.
Publicado: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
por: Muhammad Haider, et al.
Publicado: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
por: Muhammad Imran, et al.
Publicado: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
por: Sandra Irenaeus, et al.
Publicado: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
por: Alan Priester, et al.
Publicado: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
por: Austin Drysch, et al.
Publicado: (2025)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
por: Jennifer Dunsmore, et al.
Publicado: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
por: Herbert Lepor, et al.
Publicado: (2025)